“Effectiveness and Safety of the Monoclonal Antibody Drug Lecanemab (Leqembi) in Reducing Beta-Amyloid Plaques in Alzheimer’s Dementia: A Literature Review”. Journal of Health Management and Pharmacy Exploration, vol. 3, no. 1, Feb. 2025, https://doi.org/10.52465/johmpe.v3i1.547.